Evolutionary and comparative genomics to drive rational drug design, with particular focus on neuropeptide seven-transmembrane receptors

Michael Furlong, Jae Young Seong

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Seven transmembrane receptors (7TMRs), also known as G protein-coupled receptors, are popular targets of drug development, particularly 7TMR systems that are activated by peptide ligands. Although many pharmaceutical drugs have been discovered via conventional bulk analysis techniques the increasing availability of structural and evolutionary data are facilitating change to rational, targeted drug design. This article discusses the appeal of neuropeptide-7TMR systems as drug targets and provides an overview of concepts in the evolution of vertebrate genomes and gene families. Subsequently, methods that use evolutionary concepts and comparative analysis techniques to aid in gene discovery, gene function identification, and novel drug design are provided along with case study examples.

Original languageEnglish
Pages (from-to)57-68
Number of pages12
JournalBiomolecules and Therapeutics
Volume25
Issue number1
DOIs
Publication statusPublished - 2017 Jan

Keywords

  • 7TMR
  • Coevolution
  • Evolutionary history
  • G protein-coupled receptor
  • Gene duplication
  • Neuropeptide
  • Whole genome duplication

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Evolutionary and comparative genomics to drive rational drug design, with particular focus on neuropeptide seven-transmembrane receptors'. Together they form a unique fingerprint.

Cite this